Product Name
Kir6.2, Polyclonal Antibody
Full Product Name
Kir6.2 (Phospho-Thr224) Antibody
Product Synonym Names
ATP-sensitive inward rectifier potassium channel 11; IKATP; IRK11; Inward rectifier K channel Kir6.2; KCNJ11; Potassium channel inwardly rectifying subfamily J member 11
Product Gene Name
anti-Kir6.2 antibody
[Similar Products]
Product Synonym Gene Name
KCNJ11[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
3D Structure
ModBase 3D Structure for Q14654
Species Reactivity
Human, Mouse
Specificity
Kir6.2 (Phospho-Thr224) Antibody detects endogenous levels of KCNJ11 only when phosphorylated at Thr224.
Purity/Purification
Purified from rabbit antiserum by affinity-chromatography using phospho peptide. The antibody against non-phospho peptide was removed by chromatography using corresponding non-phospho peptide.
Form/Format
Rabbit IgG in phosphate buffered saline (Phospho-without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Concentration
1 mg/ml (lot specific)
Target Modification
Phospho
Modification Sites
H:T224; M:T224
Immunogen
The antiserum was produced against synthesized phospho-peptide derived from human Kir6.2 around the phosphorylation site of Thr224.
Preparation and Storage
Stable at -20 degree C for at least 1 year.
Other Notes
Small volumes of anti-Kir6.2 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Applications Tested/Suitable for anti-Kir6.2 antibody
Western Blot (WB), ELISA (EIA)
Application Notes for anti-Kir6.2 antibody
WB: 1:500~1:1000
ELISA: 1:10000
ELISA (EIA) of anti-Kir6.2 antibody
Enzyme-Linked Immunosorbent Assay (Phospho-ELISA) for Immunogen Phosphopeptide (Phospho-left) and Non-Phosphopeptide (Phospho-right), using Kir6.2 (Phospho-Thr224) Antibody

Western Blot (WB) of anti-Kir6.2 antibody
Western blot analysis of lysates from HeLa cells, using Kir6.2 (Phospho-Thr224) Antibody.

NCBI/Uniprot data below describe general gene information for Kir6.2. It may not necessarily be applicable to this product.
NCBI Accession #
NP_001159762.1
[Other Products]
NCBI GenBank Nucleotide #
NM_001166290.1
[Other Products]
UniProt Primary Accession #
Q14654
[Other Products]
UniProt Secondary Accession #
Q2M1H7; Q58EX3; Q8IW96; B4DWI4; E9PNK0[Other Products]
UniProt Related Accession #
Q14654[Other Products]
NCBI Official Full Name
ATP-sensitive inward rectifier potassium channel 11 isoform 2
NCBI Official Synonym Full Names
potassium voltage-gated channel subfamily J member 11
NCBI Official Symbol
KCNJ11??[Similar Products]
NCBI Official Synonym Symbols
BIR; HHF2; PHHI; IKATP; TNDM3; KIR6.2; MODY13
??[Similar Products]
NCBI Protein Information
ATP-sensitive inward rectifier potassium channel 11
UniProt Protein Name
ATP-sensitive inward rectifier potassium channel 11
UniProt Synonym Protein Names
IKATP; Inward rectifier K(+) channel Kir6.2; Potassium channel, inwardly rectifying subfamily J member 11
UniProt Gene Name
KCNJ11??[Similar Products]
NCBI Summary for Kir6.2
Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. The protein encoded by this gene is an integral membrane protein and inward-rectifier type potassium channel. The encoded protein, which has a greater tendency to allow potassium to flow into a cell rather than out of a cell, is controlled by G-proteins and is found associated with the sulfonylurea receptor SUR. Mutations in this gene are a cause of familial persistent hyperinsulinemic hypoglycemia of infancy (PHHI), an autosomal recessive disorder characterized by unregulated insulin secretion. Defects in this gene may also contribute to autosomal dominant non-insulin-dependent diabetes mellitus type II (NIDDM), transient neonatal diabetes mellitus type 3 (TNDM3), and permanent neonatal diabetes mellitus (PNDM). Multiple alternatively spliced transcript variants that encode different protein isoforms have been described for this gene. [provided by RefSeq, Oct 2009]
UniProt Comments for Kir6.2
This receptor is controlled by G proteins. Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium. Can be blocked by extracellular barium (). Subunit of ATP-sensitive potassium channels (KATP). Can form cardiac and smooth muscle-type KATP channels with ABCC9. KCNJ11 forms the channel pore while ABCC9 is required for activation and regulation.
Research Articles on Kir6.2
1. Upregulated KCNJ11 predicts a poor prognosis and is regulated by NFkappaB signaling in hepatocellular carcinoma (HCC). LDHA partially mediated the oncogenic roles of KCNJ11 in HCC.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.